Correction: VEGFC ameliorates salt‑sensitive hypertension and hypertensive nephropathy by inhibiting NLRP3 inflammasome via activating VEGFR3‑AMPK dependent autophagy pathway

Key Points

• VEGFC effectively reduces salt-sensitive hypertension, suggesting significant protective effects.
• Inhibition of NLRP3 inflammasome is observed, highlighting a key mechanism in this process.
• Assessment using the VEGFR3-AMPK dependent autophagy pathway elucidates underlying biological treatment strategies.
• This study underscores the importance of VEGFC in alleviating kidney damage, suggesting new directions for hypertension treatment.